PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 59 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $121,000 | -3.2% | 34,960 | -5.4% | 0.00% | – |
Q4 2020 | $125,000 | -10.1% | 36,965 | -7.0% | 0.00% | – |
Q3 2020 | $139,000 | -23.6% | 39,756 | 0.0% | 0.00% | – |
Q2 2020 | $182,000 | +33.8% | 39,756 | -3.6% | 0.00% | – |
Q1 2020 | $136,000 | -37.3% | 41,251 | +16.1% | 0.00% | – |
Q4 2019 | $217,000 | +46.6% | 35,519 | 0.0% | 0.00% | – |
Q3 2019 | $148,000 | -70.5% | 35,519 | -6.9% | 0.00% | – |
Q2 2019 | $501,000 | – | 38,169 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 6,643,704 | $27,704,000 | 2.29% |
DAFNA Capital Management LLC | 360,542 | $1,503,000 | 0.56% |
SABBY MANAGEMENT, LLC | 124,788 | $520,000 | 0.28% |
Rock Springs Capital Management LP | 1,416,900 | $5,908,000 | 0.24% |
Cormorant Asset Management, LP | 816,448 | $3,405,000 | 0.21% |
SECTORAL ASSET MANAGEMENT INC | 196,000 | $817,000 | 0.14% |
Leap Investments LP | 17,919 | $75,000 | 0.04% |
FARALLON CAPITAL MANAGEMENT LLC | 807,928 | $3,369,000 | 0.02% |
Virtus ETF Advisers LLC | 21,738 | $91,000 | 0.02% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 20,000 | $83,000 | 0.01% |